Arhets P, Gounon P, Sansonetti P, Guillén N
Unité de Pathogénie Microbienne Moléculaire, Institut National de la Santé et de la Recherche Médicale U389, Paris, France.
Infect Immun. 1995 Nov;63(11):4358-67. doi: 10.1128/iai.63.11.4358-4367.1995.
The redistribution and capping of surface receptors on the human pathogen Entamoeba histolytica was observed in the presence of concanavalin A (ConA). Capping was correlated with plasma membrane folding towards the rear of the amoeba and with uroid formation. The uroid is thought to play a role in the escape of amoebae from the host immune response. To localize myosin II during capping, amoebae were incubated in the presence of ConA and then analyzed by microscopy. Myosin II was three times more concentrated within the uroid compared with the rest of the cell, suggesting that the release of caps may depend upon mechanical contraction driven by myosin II activity. The use of drugs that disrupt cytoskeletal structure or that inhibit myosin heavy chain phosphorylation demonstrated that inhibition of capping prevents uroid formation. Biochemical analysis allowed the identification of two ConA receptors which have been previously described as major pathogenic antigens of this parasite: the 96-kDa antigen, which carries alcohol dehydrogenase 2 activity and binds extracellular matrix proteins, and the Gal-GalNAc-inhibitable surface lectin, which is involved in amoeba-cell interactions and in the degradation of complement particles attached to the parasite.
在伴刀豆球蛋白A(ConA)存在的情况下,观察到人类病原体溶组织内阿米巴表面受体的重新分布和帽化现象。帽化与质膜向阿米巴后部折叠以及尾状结构的形成相关。尾状结构被认为在阿米巴逃避宿主免疫反应中发挥作用。为了在帽化过程中定位肌球蛋白II,将阿米巴在ConA存在的情况下孵育,然后通过显微镜进行分析。与细胞的其余部分相比,肌球蛋白II在尾状结构中的浓度高出三倍,这表明帽的释放可能取决于由肌球蛋白II活性驱动的机械收缩。使用破坏细胞骨架结构或抑制肌球蛋白重链磷酸化的药物表明,帽化的抑制会阻止尾状结构的形成。生化分析鉴定出两种ConA受体,它们先前已被描述为该寄生虫的主要致病抗原:96 kDa抗原,其具有乙醇脱氢酶2活性并结合细胞外基质蛋白;以及半乳糖 - N - 乙酰半乳糖胺可抑制的表面凝集素,其参与阿米巴与细胞的相互作用以及附着于寄生虫的补体颗粒的降解。